2026 Step Therapy Criteria — select CNS drugs (antidepressants, antipsychotics, dextromethorphan/bupropion, trazodone)
Customize your policy alerts
Sign up for all Fidelis Care policy alerts
Know when Fidelis Care releases new policies or updates existing guidance.
Monitor payer policy activity
Defines step therapy coverage rules for several classes of central nervous system medications (antidepressants, oral antipsychotics, dextromethorphan/bupropion products, and trazodone) for Fidelis Care members and specifies prerequisite drug trials required for coverage.
No material clinical or coverage changes in this revision.
Coverage Criteria
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.